A single-dose combination therapy that both prevents and treats anthrax infection. (Q46032501)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

A single-dose combination therapy that both prevents and treats anthrax infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Dennis M Klinman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Debra Tross

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

1811-1815

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

Bioterrorism: a clear and present danger

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Observations on the prophylaxis of experimental pulmonary anthrax in the monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Adverse events associated with prolonged antibiotic use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Chronobiology. Suggestions for integrating it into drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Recent advances in the development of an improved, human anthrax vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Molecular pathogenesis of Bacillus anthracis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Anthrax vaccine: short-term safety experience in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Field Evaluation of a Human Anthrax Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

US soldiers refuse to fall in line with anthrax vaccination scheme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Comprehensive systematic surveillance for adverse effects of anthrax vaccine adsorbed, US Armed Forces, 1998-2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

CpG motifs in bacterial DNA trigger direct B-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis Sterne strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Effect of CpG oligonucleotides on vaccine-induced B cell memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Past, imminent and future human medical countermeasures for anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Passive antibody administration (immediate immunity) as a specific defense against biological weapons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Adjuvant activity of CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

Murine aerosol challenge model of anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

A cloned polyoma DNA fragment representing the 5' half of the early gene region is oncogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.094

7 January 2021

inferred from DOI database lookup

Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios

1 reference

12 December 2020

Occupational health guidelines for remediation workers at Bacillus anthracis-contaminated sites - United States, 2001 - 2002

1 reference

12 December 2020

1 reference

12 December 2020

Conference report on public health and clinical guidelines for anthrax

1 reference

12 December 2020

Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model

1 reference

12 December 2020

Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.

1 reference

12 December 2020

How often is medication taken as prescribed? A novel assessment technique

1 reference

12 December 2020

Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA

1 reference

12 December 2020

Anthrax pathogenesis and host response.

1 reference

12 December 2020

10.1016/J.VACCINE.2009.01.094

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

release_srcrzt66brcebkdvczwtjym6ri

27 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/srcrzt66brcebkdvczwtjym6ri

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19402202%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference